Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Comment by nodealson Sep 29, 2020 12:04pm

108 Views

Post# 31635274

RE:RE:Sensitivity and Specificity Matter

Thanks for setting that straight. it's a shame it is necessary to response to obvious mis-information.

And of course didn't provide the link!

RightSideCDN wrote: As per HC where?
Here's what it says on their webite regarding Antigen tests

https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/testing/antigen.html#a2

Health Canada considers the following to be unacceptable for authorization:

sensitivity below 80%

Sensitivity values below this level will produce too many false negative results. These tests will not be authorized, regardless of other factors.